nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Parkinson's disease	0.332	0.583	CbGaD
Bepridil—ABCB1—Parkinson's disease	0.237	0.417	CbGaD
Bepridil—CACNA1A—cerebellar cortex—Parkinson's disease	0.0164	0.0966	CbGeAlD
Bepridil—CALM1—superior cervical ganglion—Parkinson's disease	0.00829	0.0489	CbGeAlD
Bepridil—CALM2—adrenal medulla—Parkinson's disease	0.00683	0.0403	CbGeAlD
Bepridil—CALM1—adrenal medulla—Parkinson's disease	0.0068	0.0401	CbGeAlD
Bepridil—CACNA1A—nerve—Parkinson's disease	0.00601	0.0354	CbGeAlD
Bepridil—CALM1—sympathetic nervous system—Parkinson's disease	0.00453	0.0267	CbGeAlD
Bepridil—CACNA1A—hindbrain—Parkinson's disease	0.0045	0.0265	CbGeAlD
Bepridil—CALM2—pons—Parkinson's disease	0.00331	0.0195	CbGeAlD
Bepridil—CALM1—pons—Parkinson's disease	0.0033	0.0195	CbGeAlD
Bepridil—PDE1A—hindbrain—Parkinson's disease	0.00329	0.0194	CbGeAlD
Bepridil—CALM1—autonomic nervous system—Parkinson's disease	0.00304	0.0179	CbGeAlD
Bepridil—CACNA1A—brainstem—Parkinson's disease	0.00258	0.0152	CbGeAlD
Bepridil—CACNA1A—forebrain—Parkinson's disease	0.00249	0.0147	CbGeAlD
Bepridil—CALM2—peripheral nervous system—Parkinson's disease	0.00221	0.013	CbGeAlD
Bepridil—CALM1—peripheral nervous system—Parkinson's disease	0.00219	0.0129	CbGeAlD
Bepridil—PDE1B—forebrain—Parkinson's disease	0.00217	0.0128	CbGeAlD
Bepridil—PDE1A—brainstem—Parkinson's disease	0.00189	0.0111	CbGeAlD
Bepridil—PDE1A—forebrain—Parkinson's disease	0.00182	0.0107	CbGeAlD
Bepridil—CACNA1A—medulla oblongata—Parkinson's disease	0.0018	0.0106	CbGeAlD
Bepridil—TNNC1—cardiovascular system—Parkinson's disease	0.00176	0.0104	CbGeAlD
Bepridil—Ifenprodil—GRIN2B—Parkinson's disease	0.00174	0.273	CrCbGaD
Bepridil—CALM2—nerve—Parkinson's disease	0.00172	0.0101	CbGeAlD
Bepridil—CALM1—nerve—Parkinson's disease	0.00171	0.0101	CbGeAlD
Bepridil—PDE1A—cardiovascular system—Parkinson's disease	0.00154	0.00908	CbGeAlD
Bepridil—ATP1A1—hindbrain—Parkinson's disease	0.00146	0.00862	CbGeAlD
Bepridil—KCNQ1—cardiovascular system—Parkinson's disease	0.00143	0.00844	CbGeAlD
Bepridil—CACNA1A—head—Parkinson's disease	0.00143	0.00841	CbGeAlD
Bepridil—CACNA1A—nervous system—Parkinson's disease	0.00135	0.00797	CbGeAlD
Bepridil—PDE1A—medulla oblongata—Parkinson's disease	0.00132	0.00776	CbGeAlD
Bepridil—CACNA1A—central nervous system—Parkinson's disease	0.0013	0.00767	CbGeAlD
Bepridil—CALM2—hindbrain—Parkinson's disease	0.00129	0.00759	CbGeAlD
Bepridil—CALM1—hindbrain—Parkinson's disease	0.00128	0.00756	CbGeAlD
Bepridil—CACNA1A—cerebellum—Parkinson's disease	0.00127	0.0075	CbGeAlD
Bepridil—PDE1B—head—Parkinson's disease	0.00124	0.00733	CbGeAlD
Bepridil—Alverine—HTR1A—Parkinson's disease	0.00124	0.195	CrCbGaD
Bepridil—KCNQ1—medulla oblongata—Parkinson's disease	0.00122	0.00721	CbGeAlD
Bepridil—PDE1A—midbrain—Parkinson's disease	0.0012	0.00709	CbGeAlD
Bepridil—CACNA1H—cardiovascular system—Parkinson's disease	0.0012	0.00709	CbGeAlD
Bepridil—PDE1B—nervous system—Parkinson's disease	0.00118	0.00695	CbGeAlD
Bepridil—CACNA1D—forebrain—Parkinson's disease	0.00117	0.00692	CbGeAlD
Bepridil—PDE1A—spinal cord—Parkinson's disease	0.00117	0.00692	CbGeAlD
Bepridil—CACNA2D2—midbrain—Parkinson's disease	0.00116	0.00682	CbGeAlD
Bepridil—PDE1B—central nervous system—Parkinson's disease	0.00114	0.00669	CbGeAlD
Bepridil—CACNA2D2—spinal cord—Parkinson's disease	0.00113	0.00666	CbGeAlD
Bepridil—PDE1B—cerebellum—Parkinson's disease	0.00111	0.00654	CbGeAlD
Bepridil—CACNA1C—forebrain—Parkinson's disease	0.00108	0.00639	CbGeAlD
Bepridil—PDE1A—head—Parkinson's disease	0.00104	0.00615	CbGeAlD
Bepridil—CACNA1A—brain—Parkinson's disease	0.00103	0.00609	CbGeAlD
Bepridil—Benzphetamine—SLC18A2—Parkinson's disease	0.00103	0.162	CrCbGaD
Bepridil—CACNA2D2—head—Parkinson's disease	0.001	0.00592	CbGeAlD
Bepridil—CACNA1D—cardiovascular system—Parkinson's disease	0.000992	0.00585	CbGeAlD
Bepridil—PDE1A—nervous system—Parkinson's disease	0.000988	0.00583	CbGeAlD
Bepridil—KCNQ1—head—Parkinson's disease	0.000969	0.00571	CbGeAlD
Bepridil—PDE1A—central nervous system—Parkinson's disease	0.000951	0.00561	CbGeAlD
Bepridil—CACNA2D2—nervous system—Parkinson's disease	0.000951	0.00561	CbGeAlD
Bepridil—PDE1A—cerebellum—Parkinson's disease	0.00093	0.00548	CbGeAlD
Bepridil—CACNA2D2—central nervous system—Parkinson's disease	0.000916	0.0054	CbGeAlD
Bepridil—CACNA1C—cardiovascular system—Parkinson's disease	0.000916	0.0054	CbGeAlD
Bepridil—ATP1A1—embryo—Parkinson's disease	0.000914	0.00539	CbGeAlD
Bepridil—PDE1B—brain—Parkinson's disease	0.000901	0.00532	CbGeAlD
Bepridil—CACNA2D2—cerebellum—Parkinson's disease	0.000895	0.00528	CbGeAlD
Bepridil—Diphenylpyraline—SLC6A3—Parkinson's disease	0.000868	0.136	CrCbGaD
Bepridil—ATP1A1—brainstem—Parkinson's disease	0.000838	0.00494	CbGeAlD
Bepridil—ATP1A1—forebrain—Parkinson's disease	0.000809	0.00477	CbGeAlD
Bepridil—CALM2—embryo—Parkinson's disease	0.000805	0.00475	CbGeAlD
Bepridil—CALM1—embryo—Parkinson's disease	0.000802	0.00473	CbGeAlD
Bepridil—CACNA1H—nervous system—Parkinson's disease	0.000771	0.00455	CbGeAlD
Bepridil—PDE1A—brain—Parkinson's disease	0.000755	0.00445	CbGeAlD
Bepridil—CALM2—brainstem—Parkinson's disease	0.000738	0.00435	CbGeAlD
Bepridil—CALM1—brainstem—Parkinson's disease	0.000735	0.00433	CbGeAlD
Bepridil—CACNA2D2—brain—Parkinson's disease	0.000727	0.00429	CbGeAlD
Bepridil—CACNA1H—cerebellum—Parkinson's disease	0.000726	0.00428	CbGeAlD
Bepridil—CALM2—forebrain—Parkinson's disease	0.000712	0.0042	CbGeAlD
Bepridil—CYP2D6—hindbrain—Parkinson's disease	0.000711	0.00419	CbGeAlD
Bepridil—CALM1—forebrain—Parkinson's disease	0.000709	0.00418	CbGeAlD
Bepridil—KCNQ1—brain—Parkinson's disease	0.000702	0.00414	CbGeAlD
Bepridil—ATP1A1—cardiovascular system—Parkinson's disease	0.000684	0.00403	CbGeAlD
Bepridil—CACNA1D—head—Parkinson's disease	0.000672	0.00396	CbGeAlD
Bepridil—CALM3—medulla oblongata—Parkinson's disease	0.000655	0.00386	CbGeAlD
Bepridil—KCNH2—forebrain—Parkinson's disease	0.000645	0.0038	CbGeAlD
Bepridil—CACNA1D—nervous system—Parkinson's disease	0.000637	0.00376	CbGeAlD
Bepridil—CACNA1C—head—Parkinson's disease	0.00062	0.00366	CbGeAlD
Bepridil—CACNA1D—central nervous system—Parkinson's disease	0.000613	0.00362	CbGeAlD
Bepridil—CALM2—cardiovascular system—Parkinson's disease	0.000602	0.00355	CbGeAlD
Bepridil—CALM1—cardiovascular system—Parkinson's disease	0.000599	0.00354	CbGeAlD
Bepridil—CACNA1D—cerebellum—Parkinson's disease	0.000599	0.00353	CbGeAlD
Bepridil—CALM3—midbrain—Parkinson's disease	0.000599	0.00353	CbGeAlD
Bepridil—CACNA1H—brain—Parkinson's disease	0.00059	0.00348	CbGeAlD
Bepridil—CACNA1C—nervous system—Parkinson's disease	0.000588	0.00347	CbGeAlD
Bepridil—ATP1A1—medulla oblongata—Parkinson's disease	0.000584	0.00345	CbGeAlD
Bepridil—CALM3—spinal cord—Parkinson's disease	0.000584	0.00345	CbGeAlD
Bepridil—CACNA1C—central nervous system—Parkinson's disease	0.000566	0.00334	CbGeAlD
Bepridil—CACNA1C—cerebellum—Parkinson's disease	0.000553	0.00326	CbGeAlD
Bepridil—KCNH2—cardiovascular system—Parkinson's disease	0.000546	0.00322	CbGeAlD
Bepridil—ATP1A1—midbrain—Parkinson's disease	0.000534	0.00315	CbGeAlD
Bepridil—ATP1A1—spinal cord—Parkinson's disease	0.000521	0.00307	CbGeAlD
Bepridil—CALM2—medulla oblongata—Parkinson's disease	0.000515	0.00303	CbGeAlD
Bepridil—CALM1—medulla oblongata—Parkinson's disease	0.000512	0.00302	CbGeAlD
Bepridil—CACNA1D—brain—Parkinson's disease	0.000487	0.00287	CbGeAlD
Bepridil—CALM2—midbrain—Parkinson's disease	0.00047	0.00277	CbGeAlD
Bepridil—CALM1—midbrain—Parkinson's disease	0.000468	0.00276	CbGeAlD
Bepridil—KCNH2—medulla oblongata—Parkinson's disease	0.000466	0.00275	CbGeAlD
Bepridil—CALM3—cerebellum—Parkinson's disease	0.000463	0.00273	CbGeAlD
Bepridil—ATP1A1—head—Parkinson's disease	0.000463	0.00273	CbGeAlD
Bepridil—CALM2—spinal cord—Parkinson's disease	0.000459	0.00271	CbGeAlD
Bepridil—CALM1—spinal cord—Parkinson's disease	0.000457	0.00269	CbGeAlD
Bepridil—Tripelennamine—CYP2D6—Parkinson's disease	0.000456	0.0715	CrCbGaD
Bepridil—CACNA1C—brain—Parkinson's disease	0.000449	0.00265	CbGeAlD
Bepridil—ATP1A1—nervous system—Parkinson's disease	0.000439	0.00259	CbGeAlD
Bepridil—Benzphetamine—SLC6A3—Parkinson's disease	0.000427	0.067	CrCbGaD
Bepridil—KCNH2—midbrain—Parkinson's disease	0.000426	0.00251	CbGeAlD
Bepridil—ATP1A1—central nervous system—Parkinson's disease	0.000423	0.00249	CbGeAlD
Bepridil—KCNH2—spinal cord—Parkinson's disease	0.000416	0.00245	CbGeAlD
Bepridil—ATP1A1—cerebellum—Parkinson's disease	0.000413	0.00244	CbGeAlD
Bepridil—CALM2—head—Parkinson's disease	0.000408	0.0024	CbGeAlD
Bepridil—CYP2D6—brainstem—Parkinson's disease	0.000408	0.0024	CbGeAlD
Bepridil—CALM1—head—Parkinson's disease	0.000406	0.00239	CbGeAlD
Bepridil—CYP2D6—forebrain—Parkinson's disease	0.000393	0.00232	CbGeAlD
Bepridil—CALM2—nervous system—Parkinson's disease	0.000387	0.00228	CbGeAlD
Bepridil—CALM1—nervous system—Parkinson's disease	0.000385	0.00227	CbGeAlD
Bepridil—CALM3—brain—Parkinson's disease	0.000376	0.00222	CbGeAlD
Bepridil—CALM2—central nervous system—Parkinson's disease	0.000372	0.0022	CbGeAlD
Bepridil—CALM1—central nervous system—Parkinson's disease	0.000371	0.00219	CbGeAlD
Bepridil—KCNH2—head—Parkinson's disease	0.000369	0.00218	CbGeAlD
Bepridil—CALM2—cerebellum—Parkinson's disease	0.000364	0.00215	CbGeAlD
Bepridil—CALM1—cerebellum—Parkinson's disease	0.000362	0.00214	CbGeAlD
Bepridil—KCNH2—nervous system—Parkinson's disease	0.00035	0.00207	CbGeAlD
Bepridil—KCNH2—central nervous system—Parkinson's disease	0.000337	0.00199	CbGeAlD
Bepridil—ATP1A1—brain—Parkinson's disease	0.000336	0.00198	CbGeAlD
Bepridil—KCNH2—cerebellum—Parkinson's disease	0.00033	0.00194	CbGeAlD
Bepridil—ABCB1—embryo—Parkinson's disease	0.00032	0.00189	CbGeAlD
Bepridil—CALM2—brain—Parkinson's disease	0.000296	0.00174	CbGeAlD
Bepridil—CALM1—brain—Parkinson's disease	0.000294	0.00173	CbGeAlD
Bepridil—ABCB1—forebrain—Parkinson's disease	0.000283	0.00167	CbGeAlD
Bepridil—KCNH2—brain—Parkinson's disease	0.000268	0.00158	CbGeAlD
Bepridil—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.000256	0.0402	CrCbGaD
Bepridil—ABCB1—cardiovascular system—Parkinson's disease	0.000239	0.00141	CbGeAlD
Bepridil—CYP2D6—head—Parkinson's disease	0.000225	0.00133	CbGeAlD
Bepridil—CYP2D6—nervous system—Parkinson's disease	0.000214	0.00126	CbGeAlD
Bepridil—CYP2D6—central nervous system—Parkinson's disease	0.000206	0.00121	CbGeAlD
Bepridil—ABCB1—medulla oblongata—Parkinson's disease	0.000204	0.00121	CbGeAlD
Bepridil—CYP2D6—cerebellum—Parkinson's disease	0.000201	0.00119	CbGeAlD
Bepridil—ABCB1—midbrain—Parkinson's disease	0.000187	0.0011	CbGeAlD
Bepridil—ABCB1—spinal cord—Parkinson's disease	0.000182	0.00108	CbGeAlD
Bepridil—Fentanyl—ABCB1—Parkinson's disease	0.000181	0.0284	CrCbGaD
Bepridil—Diphenhydramine—CYP2D6—Parkinson's disease	0.00018	0.0282	CrCbGaD
Bepridil—CYP2D6—brain—Parkinson's disease	0.000163	0.000963	CbGeAlD
Bepridil—ABCB1—head—Parkinson's disease	0.000162	0.000956	CbGeAlD
Bepridil—ABCB1—nervous system—Parkinson's disease	0.000154	0.000906	CbGeAlD
Bepridil—ABCB1—central nervous system—Parkinson's disease	0.000148	0.000872	CbGeAlD
Bepridil—ABCB1—cerebellum—Parkinson's disease	0.000145	0.000853	CbGeAlD
Bepridil—ABCB1—brain—Parkinson's disease	0.000117	0.000693	CbGeAlD
Bepridil—PDE1B—Signaling Pathways—APOE—Parkinson's disease	1.5e-05	5.88e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR7—Parkinson's disease	1.49e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD2—Parkinson's disease	1.49e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR7—Parkinson's disease	1.49e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD2—Parkinson's disease	1.49e-05	5.87e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—IL6—Parkinson's disease	1.49e-05	5.85e-05	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—IL6—Parkinson's disease	1.48e-05	5.83e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—IL6—Parkinson's disease	1.48e-05	5.82e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—MAPK8—Parkinson's disease	1.48e-05	5.82e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GFAP—Parkinson's disease	1.48e-05	5.81e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1B—Parkinson's disease	1.47e-05	5.8e-05	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—IL6—Parkinson's disease	1.46e-05	5.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GRM5—Parkinson's disease	1.46e-05	5.74e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ADRBK1—Parkinson's disease	1.45e-05	5.72e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—IL6—Parkinson's disease	1.45e-05	5.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—IL6—Parkinson's disease	1.45e-05	5.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—IL6—Parkinson's disease	1.44e-05	5.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—IL6—Parkinson's disease	1.44e-05	5.66e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—IL6—Parkinson's disease	1.43e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—IL6—Parkinson's disease	1.43e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GFAP—Parkinson's disease	1.43e-05	5.62e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GFAP—Parkinson's disease	1.43e-05	5.62e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.42e-05	5.6e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—DDC—Parkinson's disease	1.42e-05	5.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GRM5—Parkinson's disease	1.41e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GRM5—Parkinson's disease	1.41e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ADRBK1—Parkinson's disease	1.41e-05	5.54e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ADRBK1—Parkinson's disease	1.41e-05	5.54e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—INS—Parkinson's disease	1.4e-05	5.5e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—INS—Parkinson's disease	1.37e-05	5.41e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—MAPK8—Parkinson's disease	1.35e-05	5.32e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—ADRBK1—Parkinson's disease	1.34e-05	5.28e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.34e-05	5.27e-05	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	1.34e-05	5.27e-05	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.34e-05	5.26e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HSPA1A—Parkinson's disease	1.33e-05	5.24e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ADRBK1—Parkinson's disease	1.3e-05	5.11e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ADRBK1—Parkinson's disease	1.3e-05	5.11e-05	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	1.3e-05	5.1e-05	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	1.3e-05	5.1e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HSPA1A—Parkinson's disease	1.29e-05	5.07e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HSPA1A—Parkinson's disease	1.29e-05	5.07e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.28e-05	5.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGF20—Parkinson's disease	1.28e-05	5.03e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—INS—Parkinson's disease	1.28e-05	5.03e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MAOB—Parkinson's disease	1.27e-05	4.99e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP2D6—Parkinson's disease	1.24e-05	4.89e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADORA2A—Parkinson's disease	1.24e-05	4.88e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGF20—Parkinson's disease	1.24e-05	4.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGF20—Parkinson's disease	1.24e-05	4.87e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EDN1—Parkinson's disease	1.23e-05	4.86e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CTGF—Parkinson's disease	1.22e-05	4.8e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.21e-05	4.75e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP2D6—Parkinson's disease	1.2e-05	4.73e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP2D6—Parkinson's disease	1.2e-05	4.73e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADORA2A—Parkinson's disease	1.2e-05	4.72e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.2e-05	4.72e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.2e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EDN1—Parkinson's disease	1.19e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EDN1—Parkinson's disease	1.19e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ABL1—Parkinson's disease	1.19e-05	4.66e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CTGF—Parkinson's disease	1.18e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CTGF—Parkinson's disease	1.18e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ABL1—Parkinson's disease	1.15e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ABL1—Parkinson's disease	1.15e-05	4.51e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INSR—Parkinson's disease	1.15e-05	4.5e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP2E1—Parkinson's disease	1.14e-05	4.47e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NQO1—Parkinson's disease	1.12e-05	4.42e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HGF—Parkinson's disease	1.11e-05	4.39e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—TH—Parkinson's disease	1.11e-05	4.36e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INSR—Parkinson's disease	1.11e-05	4.36e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INSR—Parkinson's disease	1.11e-05	4.36e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP2E1—Parkinson's disease	1.1e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP2E1—Parkinson's disease	1.1e-05	4.33e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NQO1—Parkinson's disease	1.09e-05	4.28e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NQO1—Parkinson's disease	1.09e-05	4.28e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGB—Parkinson's disease	1.08e-05	4.26e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HTR2A—Parkinson's disease	1.08e-05	4.25e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HGF—Parkinson's disease	1.08e-05	4.24e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HGF—Parkinson's disease	1.08e-05	4.24e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR1A—Parkinson's disease	1.08e-05	4.24e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—TH—Parkinson's disease	1.07e-05	4.22e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—TH—Parkinson's disease	1.07e-05	4.22e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYCS—Parkinson's disease	1.06e-05	4.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TAC1—Parkinson's disease	1.06e-05	4.17e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGB—Parkinson's disease	1.05e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGB—Parkinson's disease	1.05e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.04e-05	4.11e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.04e-05	4.11e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR1A—Parkinson's disease	1.04e-05	4.1e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR1A—Parkinson's disease	1.04e-05	4.1e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CASP3—Parkinson's disease	1.04e-05	4.09e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD1—Parkinson's disease	1.04e-05	4.09e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—Parkinson's disease	1.03e-05	4.07e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—Parkinson's disease	1.03e-05	4.05e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYCS—Parkinson's disease	1.03e-05	4.05e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYCS—Parkinson's disease	1.03e-05	4.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TAC1—Parkinson's disease	1.03e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TAC1—Parkinson's disease	1.03e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD3—Parkinson's disease	1.01e-05	3.96e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD1—Parkinson's disease	1.01e-05	3.96e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD1—Parkinson's disease	1.01e-05	3.96e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—Parkinson's disease	9.97e-06	3.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—Parkinson's disease	9.97e-06	3.92e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD3—Parkinson's disease	9.74e-06	3.83e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD3—Parkinson's disease	9.74e-06	3.83e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MAPK8—Parkinson's disease	9.56e-06	3.76e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CASP3—Parkinson's disease	9.51e-06	3.74e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—Parkinson's disease	9.45e-06	3.72e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—Parkinson's disease	9.44e-06	3.71e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.43e-06	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—COMT—Parkinson's disease	9.43e-06	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRBK1—Parkinson's disease	9.4e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTP1—Parkinson's disease	9.38e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MAOA—Parkinson's disease	9.36e-06	3.68e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CTGF—Parkinson's disease	9.25e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—HMOX1—Parkinson's disease	9.25e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MAPK8—Parkinson's disease	9.21e-06	3.62e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—COMT—Parkinson's disease	9.12e-06	3.59e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—COMT—Parkinson's disease	9.12e-06	3.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD2—Parkinson's disease	9.11e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR7—Parkinson's disease	9.11e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.1e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRBK1—Parkinson's disease	9.1e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MTHFR—Parkinson's disease	9.1e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTP1—Parkinson's disease	9.07e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTP1—Parkinson's disease	9.07e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MAOA—Parkinson's disease	9.05e-06	3.56e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MAOA—Parkinson's disease	9.05e-06	3.56e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—HMOX1—Parkinson's disease	8.95e-06	3.52e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—HMOX1—Parkinson's disease	8.95e-06	3.52e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MAPK8—Parkinson's disease	8.91e-06	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MAPK8—Parkinson's disease	8.91e-06	3.5e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ABCB1—Parkinson's disease	8.88e-06	3.49e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR7—Parkinson's disease	8.81e-06	3.47e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR7—Parkinson's disease	8.81e-06	3.47e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD2—Parkinson's disease	8.81e-06	3.47e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD2—Parkinson's disease	8.81e-06	3.47e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MTHFR—Parkinson's disease	8.8e-06	3.46e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MTHFR—Parkinson's disease	8.8e-06	3.46e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MAPK8—Parkinson's disease	8.74e-06	3.44e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—Parkinson's disease	8.72e-06	3.43e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.72e-06	3.43e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—Parkinson's disease	8.64e-06	3.4e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.62e-06	3.39e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTM1—Parkinson's disease	8.62e-06	3.39e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ABCB1—Parkinson's disease	8.59e-06	3.38e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ABCB1—Parkinson's disease	8.59e-06	3.38e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NQO1—Parkinson's disease	8.52e-06	3.35e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—APOE—Parkinson's disease	8.47e-06	3.33e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TH—Parkinson's disease	8.4e-06	3.3e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTM1—Parkinson's disease	8.34e-06	3.28e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTM1—Parkinson's disease	8.34e-06	3.28e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GPX1—Parkinson's disease	8.26e-06	3.25e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—APOE—Parkinson's disease	8.19e-06	3.22e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—APOE—Parkinson's disease	8.19e-06	3.22e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.12e-06	3.2e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYCS—Parkinson's disease	8.07e-06	3.17e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.03e-06	3.16e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GPX1—Parkinson's disease	7.99e-06	3.14e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GPX1—Parkinson's disease	7.99e-06	3.14e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—Parkinson's disease	7.97e-06	3.14e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TH—Parkinson's disease	7.92e-06	3.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF2—Parkinson's disease	7.63e-06	3e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MTHFR—Parkinson's disease	7.62e-06	3e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.6e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF2—Parkinson's disease	7.38e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF2—Parkinson's disease	7.38e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1R—Parkinson's disease	7.38e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MTHFR—Parkinson's disease	7.37e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MTHFR—Parkinson's disease	7.37e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EDN1—Parkinson's disease	7.29e-06	2.87e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—INS—Parkinson's disease	7.24e-06	2.85e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—COMT—Parkinson's disease	7.14e-06	2.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1R—Parkinson's disease	7.14e-06	2.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1R—Parkinson's disease	7.14e-06	2.81e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.11e-06	2.8e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MAOA—Parkinson's disease	7.09e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOE—Parkinson's disease	7.09e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EDN1—Parkinson's disease	7.05e-06	2.77e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EDN1—Parkinson's disease	7.05e-06	2.77e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HMOX1—Parkinson's disease	7.01e-06	2.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—INS—Parkinson's disease	7e-06	2.75e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—INS—Parkinson's disease	7e-06	2.75e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOE—Parkinson's disease	6.86e-06	2.7e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOE—Parkinson's disease	6.86e-06	2.7e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—COMT—Parkinson's disease	6.73e-06	2.65e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NGF—Parkinson's disease	6.7e-06	2.64e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.7e-06	2.64e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.68e-06	2.63e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.61e-06	2.6e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.53e-06	2.57e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NGF—Parkinson's disease	6.48e-06	2.55e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NGF—Parkinson's disease	6.48e-06	2.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR2A—Parkinson's disease	6.38e-06	2.51e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.34e-06	2.49e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—Parkinson's disease	6.26e-06	2.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR2A—Parkinson's disease	6.17e-06	2.43e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR2A—Parkinson's disease	6.17e-06	2.43e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.16e-06	2.42e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—Parkinson's disease	6.11e-06	2.4e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—INS—Parkinson's disease	6.06e-06	2.38e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOE—Parkinson's disease	5.93e-06	2.33e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.9e-06	2.32e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—Parkinson's disease	5.88e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—INS—Parkinson's disease	5.86e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—INS—Parkinson's disease	5.86e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—Parkinson's disease	5.85e-06	2.3e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.77e-06	2.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOE—Parkinson's disease	5.74e-06	2.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOE—Parkinson's disease	5.74e-06	2.26e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—Parkinson's disease	5.69e-06	2.24e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—Parkinson's disease	5.69e-06	2.24e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—Parkinson's disease	5.66e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—Parkinson's disease	5.66e-06	2.23e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—Parkinson's disease	5.58e-06	2.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.44e-06	2.14e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOE—Parkinson's disease	5.38e-06	2.11e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK8—Parkinson's disease	5.36e-06	2.11e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK8—Parkinson's disease	5.19e-06	2.04e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK8—Parkinson's disease	5.19e-06	2.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—Parkinson's disease	5.07e-06	1.99e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOE—Parkinson's disease	5.07e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—Parkinson's disease	4.9e-06	1.93e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—Parkinson's disease	4.9e-06	1.93e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—Parkinson's disease	4.59e-06	1.81e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—Parkinson's disease	4.33e-06	1.7e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—Parkinson's disease	3.77e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—Parkinson's disease	3.75e-06	1.47e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—Parkinson's disease	3.65e-06	1.44e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—Parkinson's disease	3.65e-06	1.44e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—Parkinson's disease	3.63e-06	1.43e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—Parkinson's disease	3.63e-06	1.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK8—Parkinson's disease	3.47e-06	1.36e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—Parkinson's disease	3.42e-06	1.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK8—Parkinson's disease	3.35e-06	1.32e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK8—Parkinson's disease	3.35e-06	1.32e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—Parkinson's disease	3.31e-06	1.3e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—Parkinson's disease	3.31e-06	1.3e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—Parkinson's disease	3.16e-06	1.24e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—Parkinson's disease	3.06e-06	1.2e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—Parkinson's disease	3.06e-06	1.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—Parkinson's disease	2.21e-06	8.71e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—Parkinson's disease	2.14e-06	8.42e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—Parkinson's disease	2.14e-06	8.42e-06	CbGpPWpGaD
